0001593968-22-000513.txt : 20220222 0001593968-22-000513.hdr.sgml : 20220222 20220222160425 ACCESSION NUMBER: 0001593968-22-000513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mara Joseph Anthony Jr CENTRAL INDEX KEY: 0001841148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 22658022 MAIL ADDRESS: STREET 1: C/O VERICEL CORPORATION STREET 2: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-02-18 0000887359 Vericel Corp VCEL 0001841148 Mara Joseph Anthony Jr C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 false true false false Chief Financial Officer Restricted Stock Unit 2022-02-18 4 A false 11018 0 A Common Stock 11018 11018 D Stock Option (right to buy) 34.90 2022-02-18 4 A false 2865 0 A 2032-02-18 Common Stock 2865 2865 D Stock Option (right to buy) 34.90 2022-02-18 4 A false 61404 0 A 2032-02-18 Common Stock 61404 61404 D Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. No expiration date for this type of award. These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. /s/ Sean Flynn, as Attorney-in-Fact for Joseph Mara 2022-02-22